HemaSphere
(Apr 2023)
Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
- Constantine Tam,
- Javier Munoz,
- Gavin Cull,
- Stephen Opat,
- Heather Allewelt,
- Xiaoping Zhang,
- Jennifer C. Stern,
- James Hilger,
- Kunthel By,
- Aileen Cohen,
- Alessandra Tedeschi
Affiliations
- Constantine Tam
- 1 Alfred Hospital and Monash University, Melbourne, VIC, Australia
- Javier Munoz
- 2 Banner MD Anderson Cancer Center, Gilbert, AZ, USA
- Gavin Cull
- 3 Sir Charles Gairdner Hospital, Perth, WA, Australia
- Stephen Opat
- 5 Monash Health, Clayton, VIC, Australia
- Heather Allewelt
- 7 BeiGene, San Mateo, CA, USA
- Xiaoping Zhang
- 7 BeiGene, San Mateo, CA, USA
- Jennifer C. Stern
- 7 BeiGene, San Mateo, CA, USA
- James Hilger
- 7 BeiGene, San Mateo, CA, USA
- Kunthel By
- 7 BeiGene, San Mateo, CA, USA
- Aileen Cohen
- 7 BeiGene, San Mateo, CA, USA
- Alessandra Tedeschi
- 8 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
- DOI
-
https://doi.org/10.1097/HS9.0000000000000870
- Journal volume & issue
-
Vol. 7,
no. 4
p.
e870
WeChat QR code